Strength
50; 100 mg/1; mg/1
Manufacturer
Merck Sharp & Dohme LLCNDC
00006307402
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/21/2017
Active Ingredients
ELBASVIR; GRAZOPREVIR ANHYDROUSApproval Type
New Drug (NDA)
FDA Application
NDA208261On Market Since
1/28/2016
Pharmacological Classes
Breast Cancer Resistance Protein Inhibitors
Breast Cancer Resistance Protein Inhibitors
Cytochrome P450 3A Inhibitors
HCV NS3/4A Protease Inhibitors
Hepatitis C Virus NS3/4A Protease Inhibitor
Hepatitis C Virus NS5A Inhibitor
Generic Alternatives
No alternatives available
No alternatives found with the same active ingredient, strength, and dosage form.
Related Drugs
Same classification
MYRBETRIQ ER 8 MG/ML SUSP
Brand
00469502099•Astellas Pharma US, Inc.
$2.2097
per ML
KALETRA 80 MG-20 MG/ML SOLN
Brand
00074395646•AbbVie Inc.
$3.1186
per ML
KATERZIA 1 MG/ML SUSPENSION
Brand
52652500101•Azurity Pharmaceuticals Inc.
$4.1914
per ML
KALETRA 200-50 MG TABLET
Brand
00074401412•AbbVie Inc.
$8.3041
per EA
KALETRA 200-50 MG TABLET
Brand
00074679922•AbbVie Inc.
$8.3041
per EA
NORVIR 100 MG TABLET
Brand
00074234030•AbbVie Inc.
$8.3462
per EA
EXFORGE HCT 5-160-25 MG TAB
Brand
00078056015•Novartis Pharmaceuticals Corporation
$8.4511
per EA
EXFORGE HCT 10-160-12.5 MG TAB
Brand
00078056115•Novartis Pharmaceuticals Corporation
$8.4532
per EA
EXFORGE HCT 5-160-12.5 MG TAB
Brand
00078055915•Novartis Pharmaceuticals Corporation
$8.5559
per EA
NORVASC 5 MG TABLET
Brand
00069153068•Pfizer Inc.
$8.6824
per EA